163 related articles for article (PubMed ID: 37678548)
1. Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms.
Guy A; Garcia G; Gourdou-Latyszenok V; Wolff-Trombini L; Josserand L; Kimmerlin Q; Favre S; Kilani B; Marty C; Boulaftali Y; Labrouche-Colomer S; Mansier O; James C
J Thromb Haemost; 2024 Jan; 22(1):172-187. PubMed ID: 37678548
[TBL] [Abstract][Full Text] [Related]
2. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.
Wolach O; Sellar RS; Martinod K; Cherpokova D; McConkey M; Chappell RJ; Silver AJ; Adams D; Castellano CA; Schneider RK; Padera RF; DeAngelo DJ; Wadleigh M; Steensma DP; Galinsky I; Stone RM; Genovese G; McCarroll SA; Iliadou B; Hultman C; Neuberg D; Mullally A; Wagner DD; Ebert BL
Sci Transl Med; 2018 Apr; 10(436):. PubMed ID: 29643232
[TBL] [Abstract][Full Text] [Related]
3. Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency.
Dou H; Kotini A; Liu W; Fidler T; Endo-Umeda K; Sun X; Olszewska M; Xiao T; Abramowicz S; Yalcinkaya M; Hardaway B; Tsimikas S; Que X; Bick A; Emdin C; Natarajan P; Papapetrou EP; Witztum JL; Wang N; Tall AR
Circulation; 2021 Dec; 144(24):1940-1954. PubMed ID: 34846914
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil elastase-deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis.
Martinod K; Witsch T; Farley K; Gallant M; Remold-O'Donnell E; Wagner DD
J Thromb Haemost; 2016 Mar; 14(3):551-8. PubMed ID: 26712312
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis in myeloproliferative neoplasms with JAK2V617F mutation.
Sun T; Zhang L
Clin Appl Thromb Hemost; 2013; 19(4):374-81. PubMed ID: 22826442
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells induce neutrophil extracellular trap formation in venous thrombosis.
Bertin FR; Rys RN; Mathieu C; Laurance S; Lemarié CA; Blostein MD
J Thromb Haemost; 2019 Feb; 17(2):403-414. PubMed ID: 30456926
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events.
Schmidt S; Daniliants D; Hiller E; Gunsilius E; Wolf D; Feistritzer C
Blood Adv; 2021 Sep; 5(18):3515-3527. PubMed ID: 34464975
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic force triggers rapid NETosis within sterile thrombotic occlusions.
Yu X; Tan J; Diamond SL
J Thromb Haemost; 2018 Feb; 16(2):316-329. PubMed ID: 29156107
[TBL] [Abstract][Full Text] [Related]
9. Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm.
Castiglione M; Jiang YP; Mazzeo C; Lee S; Chen JS; Kaushansky K; Yin W; Lin RZ; Zheng H; Zhan H
J Thromb Haemost; 2020 Dec; 18(12):3359-3370. PubMed ID: 32920974
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis among 1537 patients with JAK2
Zhang Y; Zhou Y; Wang Y; Teng G; Li D; Wang Y; Du C; Chen Y; Zhang H; Li Y; Fu L; Chen K; Bai J
Cancer Med; 2020 Mar; 9(6):2096-2105. PubMed ID: 31994332
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm.
Lamrani L; Lacout C; Ollivier V; Denis CV; Gardiner E; Ho Tin Noe B; Vainchenker W; Villeval JL; Jandrot-Perrus M
Blood; 2014 Aug; 124(7):1136-45. PubMed ID: 24951423
[TBL] [Abstract][Full Text] [Related]
12. Description of a knock-in mouse model of JAK2V617F MPN emerging from a minority of mutated hematopoietic stem cells.
Mansier O; Kilani B; Guitart AV; Guy A; Gourdou-Latyszenok V; Marty C; Parrens M; Plo I; Vainchenker W; James C
Blood; 2019 Dec; 134(26):2383-2387. PubMed ID: 31697834
[TBL] [Abstract][Full Text] [Related]
13. Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils.
Kimishima Y; Misaka T; Yokokawa T; Wada K; Ueda K; Sugimoto K; Minakawa K; Nakazato K; Ishida T; Oshima M; Koide S; Shide K; Shimoda K; Iwama A; Ikeda K; Takeishi Y
Nat Commun; 2021 Oct; 12(1):6177. PubMed ID: 34702814
[TBL] [Abstract][Full Text] [Related]
14. Loss of wild-type Jak2 allele enhances myeloid cell expansion and accelerates myelofibrosis in Jak2V617F knock-in mice.
Akada H; Akada S; Hutchison RE; Mohi G
Leukemia; 2014 Aug; 28(8):1627-35. PubMed ID: 24480985
[TBL] [Abstract][Full Text] [Related]
15. Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms.
Zhao B; Mei Y; Cao L; Zhang J; Sumagin R; Yang J; Gao J; Schipma MJ; Wang Y; Thorsheim C; Zhao L; Stalker T; Stein B; Wen QJ; Crispino JD; Abrams CS; Ji P
J Clin Invest; 2018 Jan; 128(1):125-140. PubMed ID: 29202466
[TBL] [Abstract][Full Text] [Related]
16. Interferon alpha-2 treatment reduces circulating neutrophil extracellular trap levels in myeloproliferative neoplasms.
Massarenti L; Knudsen TA; Enevold C; Skov V; Kjaer L; Larsen MK; Larsen TS; Hansen DL; Hasselbalch HC; Nielsen CH
Br J Haematol; 2023 Jul; 202(2):318-327. PubMed ID: 37211985
[TBL] [Abstract][Full Text] [Related]
17. Putative Role of Neutrophil Extracellular Trap Formation in Chronic Myeloproliferative Neoplasms.
Marković DC; Maslovarić IS; Kovačić M; Vignjević Petrinović S; Ilić VL
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901933
[TBL] [Abstract][Full Text] [Related]
18. Increased reactive oxygen species production and p47phox phosphorylation in neutrophils from myeloproliferative disorders patients with JAK2 (V617F) mutation.
Hurtado-Nedelec M; Csillag-Grange MJ; Boussetta T; Belambri SA; Fay M; Cassinat B; Gougerot-Pocidalo MA; Dang PM; El-Benna J
Haematologica; 2013 Oct; 98(10):1517-24. PubMed ID: 23975181
[TBL] [Abstract][Full Text] [Related]
19. JAK2V617F influences epigenomic changes in myeloproliferative neoplasms.
Chen CC; Chiu CC; Lee KD; Hsu CC; Chen HC; Huang TH; Hsiao SH; Leu YW
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):470-476. PubMed ID: 29066347
[TBL] [Abstract][Full Text] [Related]
20. IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms.
de Melo Campos P; Machado-Neto JA; Eide CA; Savage SL; Scopim-Ribeiro R; da Silva Souza Duarte A; Favaro P; Lorand-Metze I; Costa FF; Tognon CE; Druker BJ; Olalla Saad ST; Traina F
Oncotarget; 2016 Feb; 7(6):6948-59. PubMed ID: 26755644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
